The Outcomes of Living Donor Robotic Assisted Kidney Transplantation

Recruiting

• Conditions: Renal Failure Chronic; Kidney Transplant; Complications

• Registration Number: NCT06577805
• Lead Sponsor: West China Hospital

Brief Summary

The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-01
• Primary Completion: 2024-01-01
• Status Verified: 2024-08
• Study First Submitted: 2024-08-24
• Study First Submitted QC: 2024-08-27
• Last Update Submitted: 2024-08-27
• Study First Posted: 2024-08-29
• Last Update Posted: 2024-08-29
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

1. living-donor kidney transplant recipients
2. receiving standard triad immunosuppressive regimen

Exclusion Criteria

1. active infection
2. multi-organ transplantation
3. malignancy history in the donor and recipient
4. human immunodeficiency virus infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The graft function of recipients	in the follow-up period，about six months to one year	the graft function of recipients per month after transplant surgery, assessed by the serum creatinine (umol/L) and estimated glomerular function rate (eGFR).

Secondary Outcome Measures

Name	Time	Method
total operative time	about 150 minutes to 300 minutes	The time from the beginning of the procedure to the end of the procedure (minute)

Trial Locations

Locations (1)

West China Hospital, Sichuan University; 🇨🇳 Chengdu, Sichuan, China